Monte Rosa Therapeutics, Inc. Common Stock (NASDAQ: GLUE) last traded at $14.30, down 3.25% on the session. The quote above updates while this page is open; the figures below are drawn from Monte Rosa Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Monte Rosa Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker GLUE. Its market capitalisation is $1.22 billion.
Valuation measures for Monte Rosa Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.22B |
|---|---|
| Enterprise value | $1.33B |
| Price / sales | 42.47 |
| Price / book | 2.50 |
| Beta | 0.95 |
Trailing-twelve-month figures tagged in Monte Rosa Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $28.73M |
|---|---|
| Net income (TTM) | -$161.09M |
| Operating margin | -633.04% |
| Return on equity | -33.06% |
| Cash | $90.10M |
Range and volume for GLUE over the past 52 weeks.
| 52-week high | $25.77 |
|---|---|
| 52-week low | $4.54 |
| Volume | 945.6K |
| Average volume | 1.41M |
| Previous close | $14.78 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.